DE69221225D1 - Verfahren zum Reinigen von Hepatits-A-Virus (HAV), so gereinigter Virus und Impfstoffzusammensetzungen, die ihn enthalten - Google Patents

Verfahren zum Reinigen von Hepatits-A-Virus (HAV), so gereinigter Virus und Impfstoffzusammensetzungen, die ihn enthalten

Info

Publication number
DE69221225D1
DE69221225D1 DE69221225T DE69221225T DE69221225D1 DE 69221225 D1 DE69221225 D1 DE 69221225D1 DE 69221225 T DE69221225 T DE 69221225T DE 69221225 T DE69221225 T DE 69221225T DE 69221225 D1 DE69221225 D1 DE 69221225D1
Authority
DE
Germany
Prior art keywords
virus
purification
hepatits
hav
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69221225T
Other languages
English (en)
Other versions
DE69221225T2 (de
Inventor
Vittoria Pellegrini
Nicoletta Fineschi
Arie J Zuckerman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GSK Vaccines SRL
Original Assignee
Biocine SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocine SpA filed Critical Biocine SpA
Application granted granted Critical
Publication of DE69221225D1 publication Critical patent/DE69221225D1/de
Publication of DE69221225T2 publication Critical patent/DE69221225T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32451—Methods of production or purification of viral material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69221225T 1991-06-18 1992-06-05 Verfahren zum Reinigen von Hepatits-A-Virus (HAV), so gereinigter Virus und Impfstoffzusammensetzungen, die ihn enthalten Expired - Lifetime DE69221225T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI911662A IT1248075B (it) 1991-06-18 1991-06-18 Processo per la purificazione del virus dell'epatite a (hav), virus cosi` purificato e composizioni vaccinali che lo contengono.

Publications (2)

Publication Number Publication Date
DE69221225D1 true DE69221225D1 (de) 1997-09-04
DE69221225T2 DE69221225T2 (de) 1998-03-19

Family

ID=11360137

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69221225T Expired - Lifetime DE69221225T2 (de) 1991-06-18 1992-06-05 Verfahren zum Reinigen von Hepatits-A-Virus (HAV), so gereinigter Virus und Impfstoffzusammensetzungen, die ihn enthalten

Country Status (8)

Country Link
US (2) US5607851A (de)
EP (1) EP0522291B1 (de)
JP (1) JPH07177882A (de)
AT (1) ATE156187T1 (de)
DE (1) DE69221225T2 (de)
DK (1) DK0522291T3 (de)
ES (1) ES2104771T3 (de)
IT (1) IT1248075B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ225583A (en) * 1987-08-06 1991-07-26 Merck & Co Inc Process for purifying hepatitis a virions (hav)
USRE37303E1 (en) * 1992-01-10 2001-07-31 Institut National Del La Sante Et De La Recherche Medicale Imidazole compounds and their therapeutic applications
FR2686084B1 (fr) * 1992-01-10 1995-12-22 Bioprojet Soc Civ Nouveaux derives de l'imidazole, leur preparation et leurs applications therapeutiques.
FR2696748B1 (fr) * 1992-10-14 1994-12-30 Pasteur Merieux Serums Vacc Procédé de préparation d'antigènes et de vaccins de l'hépatite A (HAV).
US6143548A (en) 1995-08-30 2000-11-07 Genzyme Corporation Chromatographic purification of adeno-associated virus (AAV)
ATE550429T1 (de) * 1996-11-20 2012-04-15 Crucell Holland Bv Adenovirus-zusammensetzungen erhältlich durch ein verbessertes produktions- und reinigungsverfahren
US7732129B1 (en) * 1998-12-01 2010-06-08 Crucell Holland B.V. Method for the production and purification of adenoviral vectors
US20080261289A1 (en) * 1996-12-13 2008-10-23 Schering-Plough Corporation Compositions comprising viruses and methods for concentrating virus preparations
DE69737364T2 (de) * 1996-12-13 2007-11-29 Schering Corp. Methoden zur virus-reinigung
US6261823B1 (en) 1996-12-13 2001-07-17 Schering Corporation Methods for purifying viruses
US6544769B1 (en) * 1996-12-13 2003-04-08 Schering Corporation Compostions comprising viruses and methods for concentrating virus preparations
US6689600B1 (en) 1998-11-16 2004-02-10 Introgen Therapeutics, Inc. Formulation of adenovirus for gene therapy
US6855535B2 (en) * 2001-12-10 2005-02-15 Baxter Healthcare S.A. Method of large scale production of Hepatitis A virus
US7901921B2 (en) * 2004-10-22 2011-03-08 Oncolytics Biotech Inc. Viral purification methods
JP2008518632A (ja) * 2004-11-03 2008-06-05 イントロゲン セラピューティックス， インコーポレイテッド アデノウイルスベクターの製造および精製のための新規方法
JP4670583B2 (ja) * 2005-10-20 2011-04-13 チッソ株式会社 水溶性カチオン性磁気微粒子を用いた脂質ベシクルの分離又は検出方法
US20110165645A1 (en) * 2008-02-12 2011-07-07 Yelin Xiong Methods Using Ion Exchange and Gel Filtration Chromatography for Poxvirus Purification
CN102985536B (zh) 2010-04-14 2017-12-05 Emd密理博公司 生产高效价、高纯度的病毒母液的方法及使用其的方法
CN101816786B (zh) * 2010-04-30 2012-09-05 长春生物制品研究所有限责任公司 一种甲型肝炎灭活疫苗及其制备方法
EP3695849A1 (de) 2019-02-13 2020-08-19 Mediagnost Gesellschaft für Forschung und Herstellung von Diagnostika GmbH Verfahren zur extraktion eines antigens des hepatitis-a-virus (hav) aus einer zellkultur
WO2021255835A1 (ja) * 2020-06-16 2021-12-23 ＨＯＹＡ Ｔｅｃｈｎｏｓｕｒｇｉｃａｌ株式会社 アパタイトカラムを使用したウイルスの精製方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8205892D0 (sv) * 1982-10-18 1982-10-18 Bror Morein Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
US4624918A (en) * 1984-07-09 1986-11-25 Genentech, Inc. Purification process for hepatitis surface antigen and product thereof
JPS6147185A (ja) * 1984-08-09 1986-03-07 Chemo Sero Therapeut Res Inst 日本脳炎ウイルスの精製方法
JPS6147186A (ja) * 1984-08-09 1986-03-07 Chemo Sero Therapeut Res Inst インフルエンザウイルスの精製方法
US4673634A (en) * 1985-03-08 1987-06-16 The United States Of America As Represented By The Department Of Health And Human Services Purified antigen from non-A, non-B hepatitis causing factor
NZ225583A (en) * 1987-08-06 1991-07-26 Merck & Co Inc Process for purifying hepatitis a virions (hav)
US5011915A (en) * 1987-10-26 1991-04-30 Merck & Co., Inc. Process for purifying recombinant hepatitis antigens
AU3063389A (en) * 1988-01-08 1989-08-01 Dpz Deutsches Primatenzentrum Gesellschaft M.B.H. Hiv-2-type retroviruses of primates, vaccines, diagnostic and pharmaceutical compositions
US5004688A (en) * 1988-04-15 1991-04-02 Phillips Petroleum Company Purification of hepatitis proteins
JPH085804B2 (ja) * 1988-04-28 1996-01-24 財団法人化学及血清療法研究所 Ａ型及びｂ型肝炎混合アジュバントワクチン

Also Published As

Publication number Publication date
ITMI911662A0 (it) 1991-06-18
US5607851A (en) 1997-03-04
ITMI911662A1 (it) 1992-12-18
EP0522291B1 (de) 1997-07-30
US5719049A (en) 1998-02-17
DE69221225T2 (de) 1998-03-19
JPH07177882A (ja) 1995-07-18
ATE156187T1 (de) 1997-08-15
ES2104771T3 (es) 1997-10-16
DK0522291T3 (da) 1997-08-18
IT1248075B (it) 1995-01-05
EP0522291A1 (de) 1993-01-13

Similar Documents

Publication Publication Date Title
DE69221225T2 (de) Verfahren zum Reinigen von Hepatits-A-Virus (HAV), so gereinigter Virus und Impfstoffzusammensetzungen, die ihn enthalten
FR2603581B1 (fr) Procede pour isoler et purifier des aminoacides par chromatographie
SE8402861D0 (sv) Rening av biologiskt material
FR2619380B1 (fr) Procede de recuperation de l-amino-acides de liqueurs de fermentation les contenant
DE68907388D1 (de) Gereinigte protein a-zusammensetzungen und verfahren zu ihrer herstellung.
DE3886237D1 (de) Reinigung von LFA-3.
DE3574125D1 (en) Method of purifying waste water
ATE92335T1 (de) Reinigung von keuchhustenantigenen.
DK421089A (da) Fremgangsmaade og anordning til elektroforetisk adskillelse, rensning og berigelse af ladede eller polariserbare makromolekyler
ATE175206T1 (de) Enzymatisches reinigungsverfahren
FI945322A (fi) Menetelmä 2',3'-didehydro-2',3'-dideoksinukleosidien laajamittaista valmistusta varten
DE69324645D1 (de) Verfahren zur Herstellung von Hepatitis Antigenen und Impfstoffen
CO4480040A1 (es) Proceso de purificacion del antigeno de superficie viral hepatitis b que comprende el peptido pres 2
FR2314140A1 (fr) Procede de purification d'acide sulfurique contenant de l'acide acetique
FR2432499A1 (fr) Procede de purification d'amines tertiaires
DK0383645T3 (da) Fremgangsmåde til fremstilling af antihæmofilifaktor (FVIIIc) med meget høj renhed
FR2308401A1 (fr) Procede de separation des isotopes de l'uranium par excitation infrarouge
BE825056A (fr) Procede de purification de l'acide 11-cyano-undecanoique
SU564260A1 (ru) Способ очистки отработанной серной кислоты от органических примесей
OA07718A (fr) Procédé de purification de solutions organiques aminées uranifères et/ou molybdènifères contenant du zirconium et/ou du hafnium entre autres impuretés.
RO77317A2 (ro) Procedeu de obtinere si purificare a esterului 0-0,dimetil-1-hidroxi-2,2-2-tricloretilfosfonic
RO92381A2 (ro) Procedeu de recuperare a cioburilor de sticla
JPS5623890A (en) Purification of yeast protease b
TH933A (th) กรรมวิธีของการผลิตสตีวิโอไซต์บริสุทธิ์
IT1033664B (it) Impianto di depurazione biologica per inquinamenti organici

Legal Events

Date Code Title Description
8364 No opposition during term of opposition